Chemokines and their receptors in allergic disease

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 2, 2006, Pages 305-318

  Pease, James Edward ^a   Williams, Timothy John ^a  

^a National Heart and Lung Institute   (United Kingdom)

Author keywords

allergy; antagonist; asthma; Chemokine; chemokine receptor; chemotaxis; leukocyte migration

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); A 122058; BANYU J113863; CELL SURFACE PROTEIN; CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR3 ANTAGONIST; CHEMOKINE RECEPTOR CCR9 ANTAGONIST; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; G PROTEIN COUPLED RECEPTOR; GSK 766994; GW 701897B; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; UCB 35625; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ALLERGIC REACTION; ALLERGIC RHINITIS; ALLERGY; ASTHMA; BASOPHIL; CELL INTERACTION; CELL MATURATION; CELLULAR DISTRIBUTION; CHEMOTAXIS; CYTOLOGY; DENDRITIC CELL; EOSINOPHIL; HLA TYPING; HUMAN; HYPOTHESIS; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE; LEUKOCYTE MIGRATION; MAST CELL; NONHUMAN; OLFACTORY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; RECEPTOR BLOCKING; REVIEW; SIGNAL DETECTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CHEMOKINES; DENDRITIC CELLS; HUMANS; HYPERSENSITIVITY; INFLAMMATION; LEUKOCYTES; RECEPTORS, CHEMOKINE;

EID: 33746568035     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.06.010     Document Type: Review

References (186)

1. Rot A., and Von Andrian U.H. Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu Rev Immunol 22 (2004) 891-928
2. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
3. 3C motif. Nature 385 (1997) 640-644
4. Burrows S.D., Doyle M.L., Murphy K.P., Franklin S.G., White J.R., Brooks I., et al. Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations. Biochemistry 33 (1994) 12741-12745
5. Matloubian M., David A., Engel S., Ryan J.E., and Cyster J.G. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1 (2000) 298-304
6. Garton K.J., Gough P.J., Blobel C.P., Murphy G., Greaves D.R., Dempsey P.J., et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276 (2001) 37993-38001
7. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 (2006) 610-621
8. Fredriksson R., Lagerstrom M.C., Lundin L.G., and Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63 (2003) 1256-1272
9. Murphy P.M. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 54 (2002) 227-229
10. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52 (2000) 145-176
11. Lu Z.H., Wang Z.X., Horuk R., Hesselgesser J., Lou Y.C., Hadley T.J., et al. The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J Biol Chem 270 (1995) 26239-26245
12. Duchesnes C.E., Murphy P.M., Williams T.J., and Pease J.E. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines. Mol Immunol 43 (2006) 1221-1231
13. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187 (1998) 129-134
14. Sallusto F., Lenig D., Mackay C.R., and Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarised T helper 1 and 2 lymphocytes. J Exp Med 187 (1998) 875-883
15. Ma W., Bryce P.J., Humbles A.A., Laouini D., Yalcindag A., Alenius H., et al. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 109 (2002) 621-628
16. Gurish M.F., Humbles A., Tao H., Finkelstein S., Boyce J.A., Gerard C., et al. CCR3 is required for tissue eosinophilia and larval cytotoxicity after infection with Trichinella spiralis. J Immunol 168 (2002) 5730-5736
17. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
18. Ballesteros J.A., Jensen A.D., Liapakis G., Rasmussen S.G., Shi L., Gether U., et al. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem 276 (2001) 29171-29177
19. Auger G.A., Pease J.E., Shen X., Xanthou G., and Barker M.D. Alanine scanning mutagenesis of CCR3 reveals that the three intracellular loops are essential for functional receptor expression. Eur J Immunol 32 (2002) 1052-1058
20. Monteclaro F.S., and Charo I.F. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J Biol Chem 271 (1996) 19084-19092
21. Pease J.E., Wang J., Ponath P.D., and Murphy P.M. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1α and eotaxin binding, respectively, but a second domain is essential for receptor activation. J Biol Chem 273 (1998) 19972-19976
22. Bannert N., Craig S., Farzan M., Sogah D., Santo N.V., Choe H., et al. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J Exp Med 194 (2001) 1661-1673
23. Farzan M., Mirzabekov T., Kolchinsky P., Wyatt R., Cayabyab M., Gerard N.P., et al. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96 (1999) 667-676
24. Janetopoulos C., Jin T., and Devreotes P. Receptor-mediated activation of heterotrimeric G-proteins in living cells. Science 291 (2001) 2408-2411
25. Blanpain C., Doranz B.J., Bondue A., Govaerts C., De Leener A., Vassart G., et al. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J Biol Chem 278 (2003) 5179-5187
26. Govaerts C., Bondue A., Springael J.Y., Olivella M., Deupi X., Le Poul E., et al. Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3. J Biol Chem 278 (2003) 1892-1903
27. Gong J.H., Uguccioni M., Dewald B., Baggiolini M., and Clark-Lewis I. RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 271 (1996) 10521-10527
28. Proudfoot A.E.I., Power C.A., Hoogerwerf A.J., Montjovent M.-C., Borlat F., Offord R.E., et al. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem 271 (1996) 2599-2603
29. Simmons G., Clapham P.R., Picard L., Offord R.E., Rosenkilde M.M., Schwartz T.W., et al. Potent inhibition of HIV-1 infectivity in macrophage and lymphocytes by a novel CCR5 antagonist. Science 276 (1997) 276-279
30. Oravecz T., Pall M., Roderiquez G., Gorrell M.D., Ditto M., Nguyen N.Y., et al. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med 186 (1997) 1865-1872
31. Proost P., Struyf S., Schols D., Opdenakker G., Sozzani S., Allavena P., et al. Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. J Biol Chem 274 (1999) 3988-3993
32. Struyf S., Proost P., Schols D., De Clercq E., Opdenakker G., Lenaerts J.P., et al. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol 162 (1999) 4903-4909
33. Ali H., Richardson R.M., Haribabu B., and Snyderman R. Chemoattractant receptor cross-desensitization. J Biol Chem 274 (1999) 6027-6030
34. Bohm S.K., Grady E.F., and Bunnett N.W. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J 322 (1997) 1-18
35. Sabroe I., Williams T.J., Hebert C.A., and Collins P.D. Chemoattractant cross-desensitisation of the human neutrophil interleukin-8 receptor involves receptor internalisation and differential receptor subtype regulation. J Immunol 158 (1997) 1361-1369
36. Fong A.M., Premont R.T., Richardson R.M., Yu Y.R., Lefkowitz R.J., and Patel D.D. Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci U S A 99 (2002) 7478-7483
37. Walker J.K., Fong A.M., Lawson B.L., Savov J.D., Patel D.D., Schwartz D.A., et al. Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest 112 (2003) 566-574
38. McDonald P.H., Chow C.W., Miller W.E., Laporte S.A., Field M.E., Lin F.T., et al. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290 (2000) 1574-1577
39. Barlic J., Andrews J.D., Kelvin A.A., Bosinger S.E., DeVries M.E., Xu L., et al. Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI. Nat Immunol 1 (2000) 227-233
40. Kang J., Shi Y., Xiang B., Qu B., Su W., Zhu M., et al. A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123 (2005) 833-847
41. Thelen M., Peveri P., Kernen P., Von Tscharner V., Walz A., and Baggiolini M. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 2 (1988) 2702-2706
42. Turner L., Ward S.G., and Westwick J. A role for phosphoinositide 3-kinase in RANTES induced chemotaxis of T lymphocytes. Biochem Soc Trans 23 suppl (1995) 283S
43. Cronshaw D.G., Owen C., Brown Z., and Ward S.G. Activation of phosphoinositide 3-kinases by the CCR4 ligand macrophage-derived chemokine is a dispensable signal for T lymphocyte chemotaxis. J Immunol 172 (2004) 7761-7770
44. Rothenberg M.E., MacLean J.A., Pearlman E., Luster A.D., and Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 185 (1997) 785-790
45. Yang Y., Loy J., Ryseck R.P., Carrasco D., and Bravo R. Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood 92 (1998) 3912-3923
46. Humbles A.A., Lu B., Friend D.S., Okinaga S., Lora J., Al-Garawi A., et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A 99 (2002) 1479-1484
47. Goodarzi K., Goodarzi M., Tager A.M., Luster A.D., and von Andrian U.H. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 4 (2003) 965-973
48. Weller C.L., Collington S.J., Brown J.K., Miller H.R., Al-Kashi A., Clark P., et al. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med 201 (2005) 1961-1971
49. Sehmi R., Wardlaw A.J., Cromwell O., Kurihara K., Waltmann P., and Kay A.B. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79 (1992) 2952-2959
50. Shahabuddin S., Ponath P., and Schleimer R.P. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines. J Immunol 164 (2000) 3847-3854
51. Devouassoux G., Metcalfe D.D., and Prussin C. Eotaxin potentiates antigen-dependent basophil IL-4 production. J Immunol 163 (1999) 2877-2882
52. Penna G., Sozzani S., and Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 167 (2001) 1862-1866
53. Power C.A., Church D.J., Meyer A., Alouani S., Proudfoot A.E., Clark-Lewis I., et al. Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med 186 (1997) 825-835
54. Greaves D.R., Wang W., Dairaghi D.J., Dieu M.C., Saint-Vis B., Franz-Bacon K., et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med 186 (1997) 837-844
55. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188 (1998) 373-386
56. Sozzani S., Allavena P., D'Amico G., Luini W., Bianchi G., Kataura M., et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 161 (1998) 1083-1086
57. Saeki T., Ohwaki K., Naya A., Kobayashi K., Ishikawa M., Ohtake N., et al. Identification of a potent and nonpeptidyl ccr3 antagonist. Biochem Biophys Res Commun 281 (2001) 779-782
58. Yoshida R., Imai T., Hieshima K., Kusada J., Baba M., Kitaura M., et al. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem 272 (1997) 13803-13809
59. Tang H.L., and Cyster J.G. Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 284 (1999) 819-822
60. Gunn M.D., Kyuwa S., Tam C., Kakiuchi T., Matsuzawa A., Williams L.T., et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189 (1999) 451-460
61. Forster R., Schubel A., Breitfeld D., Kremmer E., Renner-Muller I., Wolf E., et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99 (1999) 23-33
62. Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J., et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21 (2004) 279-288
63. Hammad H., Lambrecht B.N., Pochard P., Gosset P., Marquillies P., Tonnel A.B., et al. Monocyte-derived dendritic cells induce a house dust mite-specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement of CCR7. J Immunol 169 (2002) 1524-1534
64. Fainaru O., Shseyov D., Hantisteanu S., and Groner Y. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc Natl Acad Sci U S A 102 (2005) 10598-10603
65. Haagerup A., Bjerke T., Schiotz P.O., Binderup H.G., Dahl R., and Kruse T.A. Asthma and atopy-a total genome scan for susceptibility genes. Allergy 57 (2002) 680-686
66. Bromley S.K., Thomas S.Y., and Luster A.D. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 6 (2005) 895-901
67. Debes G.F., Arnold C.N., Young A.J., Krautwald S., Lipp M., Hay J.B., et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol 6 (2005) 889-894
68. Bleul C.C., Wu L., Hoxie J.A., Springer T.A., and Mackay C.R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci U S A 94 (1997) 1925-1930
69. Jourdan P., Abbal C., Noraz N., Hori T., Uchiyama T., Vendrell J.P., et al. IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J Immunol 160 (1998) 4153-4157
70. Gonzalo J.A., Lloyd C.M., Peled A., Delaney T., Coyle A.J., and Gutierrez-Ramos J.C. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J Immunol 165 (2000) 499-508
71. Lukacs N.W., Berlin A., Schols D., Skerlj R.T., and Bridger G.J. AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. Am J Pathol 160 (2002) 1353-1360
72. Sallusto F., Mackay C.R., and Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18 (2000) 593-620
73. Morgan A.J., Symon F.A., Berry M.A., Pavord I.D., Corrigan C.J., and Wardlaw A.J. IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4. J Allergy Clin Immunol 116 (2005) 594-600
74. Pilette C., Francis J.N., Till S.J., and Durham S.R. CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge. Eur Respir J 23 (2004) 876-884
75. Bochner B.S., Hudson S.A., Xiao H.Q., and Liu M.C. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. J Allergy Clin Immunol 112 (2003) 930-934
76. Panina-Bordignon P., Papi A., Mariani M., Di Lucia P., Casoni G., Bellettato C., et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 107 (2001) 1357-1364
77. Lloyd C.M., Delaney T., Nguyen T., Tian J., Martinez- A.C., Coyle A.J., et al. CC Chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 191 (2000) 265-273
78. Gu L., Tseng S., Horner R.M., Tam C., Loda M., and Rollins B.J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404 (2000) 407-411
79. Gonzalo J.-A., Lloyd C.M., Wen D., Albar J.P., Wells T.N.C., Proudfoot A., et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airways hyperresponsiveness. J Exp Med 188 (1998) 157-167
80. Campbell E.M., Charo I.F., Kunkel S.L., Strieter R.M., Boring L., Gosling J., et al. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. J Immunol 163 (1999) 2160-2167
81. Warmington K.S., Boring L., Ruth J.H., Sonstein J., Hogaboam C.M., Curtis J.L., et al. Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses. Am J Pathol 154 (1999) 1407-1416
82. Kim Y., Sung S., Kuziel W.A., Feldman S., Fu S.M., and Rose C.E. Enhanced airway Th2 response after allergen challenge in mice deficient in CC chemokine receptor-2 (CCR2). J Immunol 166 (2001) 5183-5192
83. Blease K., Mehrad B., Standiford T.J., Lukacs N.W., Gosling J., Boring L., et al. Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice. J Immunol 165 (2000) 2603-2611
84. Koth L.L., Rodriguez M.W., Bernstein X.L., Chan S., Huang X., Charo I.F., et al. Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2. Respir Res 5 (2004) 12
85. Chvatchko Y., Hoogewerf A.J., Meyer A., Alouani S., Juillard P., Buser R., et al. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J Exp Med 191 (2000) 1755-1764
86. Schuh J.M., Power C.A., Proudfoot A.E., Kunkel S.L., Lukacs N.W., and Hogaboam C.M. Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice. FASEB J 16 (2002) 1313-1315
87. Conroy D.M., Jopling L.A., Lloyd C.M., Hodge M.R., Andrew D.P., Williams T.J., et al. CCR4 blockade does not inhibit allergic airways inflammation. J Leukoc Biol 74 (2003) 558-563
88. Chung C.D., Kuo F., Kumer J., Motani A.S., Lawrence C.E., Henderson Jr. W.R., et al. CCR8 is not essential for the development of inflammation in a mouse model of allergic airway disease. J Immunol 170 (2003) 581-587
89. Goya I., Villares R., Zaballos A., Gutierrez J., Kremer L., Gonzalo J.A., et al. Absence of CCR8 does not impair the response to ovalbumin-induced allergic airway disease. J Immunol 170 (2003) 2138-2146
90. Bishop B., and Lloyd C.M. CC chemokine ligand 1 promotes recruitment of eosinophils but not Th2 cells during the development of allergic airways disease. J Immunol 170 (2003) 4810-4817
91. Chensue S.W., Lukacs N.W., Yang T.Y., Shang X., Frait K.A., Kunkel S.L., et al. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in cc chemokine receptor 8 knockout mice. J Exp Med 193 (2001) 573-584
92. Fulkerson P.C., Zimmermann N., Brandt E.B., Muntel E.E., Doepker M.P., Kavanaugh J.L., et al. Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9). Proc Natl Acad Sci U S A 101 (2004) 1987-1992
93. Loetscher P., Pellegrino A., Gong J.H., Mattioli I., Loetscher M., Bardi G., et al. The ligands of CXC chemokine receptor 3, IFN-γ-inducible T-cell chemoattractant, Mig and IP10, are natural antagonists for CCR3. J Biol Chem 276 (2001) 2986-2991
94. Xanthou G., Duchesnes C.E., Williams T.J., and Pease J.E. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11. Eur J Immunol 33 (2003) 2241-2250
95. Stassen M., Jonuleit H., Muller C., Klein M., Richter C., Bopp T., et al. Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of Th2 cells. J Immunol 173 (2004) 267-274
96. Bellinghausen I., Klostermann B., Knop J., and Saloga J. Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 111 (2003) 862-868
97. Ling E.M., Smith T., Nguyen X.D., Pridgeon C., Dallman M., Arbery J., et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363 (2004) 608-615
98. Iellem A., Mariani M., Lang R., Recalde H., Panina-Bordignon P., Sinigaglia F., et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194 (2001) 847-853
99. Sebastiani S., Allavena P., Albanesi C., Nasorri F., Bianchi G., Traidl C., et al. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 166 (2001) 996-1002
100. Freeman C.M., Chiu B.C., Stolberg V.R., Hu J., Zeibecoglou K., Lukacs N.W., et al. CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice. J Immunol 174 (2005) 1962-1970
101. Dellabona P., Padovan E., Casorati G., Brockhaus M., and Lanzavecchia A. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J Exp Med 180 (1994) 1171-1176
102. Motsinger A., Haas D.W., Stanic A.K., Van Kaer L., Joyce S., and Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 195 (2002) 869-879
103. Kim C.H., Johnston B., and Butcher E.C. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100 (2002) 11-16
104. Bilenki L., Yang J., Fan Y., Wang S., and Yang X. Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur J Immunol 34 (2004) 345-354
105. Kimura T., Ishii Y., Morishima Y., Shibuya A., Shibuya K., Taniguchi M., et al. Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis. J Immunol 172 (2004) 5782-5789
106. Sen Y., Yongyi B., Yuling H., Luokun X., Li H., Jie X., et al. V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement. J Immunol 175 (2005) 4914-4926
107. Eum S.Y., Haile S., Lefort J., Huerre M., and Vargaftig B.B. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci U S A 92 (1995) 12290-12294
108. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., and Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183 (1996) 195-201
109. Leckie M.J., ten Brinke A., Khan J., Diamant Z., O'Connor B.J., Walls C.M., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356 (2000) 2144-2148
110. Humbles A.A., Lloyd C.M., McMillan S.J., Friend D.S., Xanthou G., McKenna E.E., et al. A critical role for eosinophils in allergic airways remodeling. Science 305 (2004) 1776-1779
111. Lee J.J., Dimina D., Macias M.P., Ochkur S.I., McGarry M.P., O'Neill K.R., et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305 (2004) 1773-1776
112. Flood-Page P., Menzies-Gow A., Phipps S., Ying S., Wangoo A., Ludwig M.S., et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112 (2003) 1029-1036
113. Jose P.J., Griffiths-Johnson D.A., Collins P.D., Walsh D.T., Moqbel R., Totty N.F., et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J Exp Med 179 (1994) 881-887
114. Patel V.P., Kreider B.L., Li Y., Li H., Leung K., Salcedo T., et al. Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med 185 (1997) 1163-1172
115. White J.R., Imburgia C., Dul E., Appelbaum E., O'Donnell K., O'Shannessy D.J., et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol 62 (1997) 667-675
116. Forssmann U., Uguccioni M., Loetscher P., Dahinden C.A., Langen H., Thelen M., et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 185 (1997) 2171-2176
117. Kitaura M., Suzuki N., Imai T., Takagi S., Suzuki R., Nakajima T., et al. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem 274 (1999) 27975-27980
118. Shinkai A., Yoshisue H., Koike M., Shoji E., Nakagawa S., Saito A., et al. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4- stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 163 (1999) 1602-1610
119. Ponath P.D., Qin S., Post T.W., Wang J., Wu L., Gerard N.P., et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 183 (1996) 2437-2448
120. Uguccioni M., Mackay C.R., Ochensberger B., Loetscher P., Rhis S., LaRosa G.J., et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 100 (1997) 1137-1143
121. Ochi H., Hirani W.M., Yuan Q., Friend D.S., Austen K.F., and Boyce J.A. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 190 (1999) 267-280
122. Sallusto F., Mackay C.R., and Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277 (1997) 2005-2007
123. Humbles A.A., Conroy D.M., Marleau S., Rankin S.M., Palframan R.T., Proudfoot A.E.I., et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 186 (1997) 601-612
124. Zimmermann N., Hogan S.P., Mishra A., Brandt E.B., Bodette T.R., Pope S.M., et al. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 165 (2000) 5839-5846
125. Collins P.D., Marleau S., Griffiths-Johnson D.A., Jose P.J., and Williams T.J. Co-operation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182 (1995) 1169-1174
126. Palframan R.T., Collins P.D., Williams T.J., and Rankin S.M. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91 (1998) 2240-2248
127. Palframan R.T., Collins P.D., Severs N.J., Rothery S., Williams T.J., and Rankin S.M. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med 188 (1998) 1621-1632
128. Sabroe I., Hartnell A., Jopling L.A., Bel S., Ponath P.D., Pease J.E., et al. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol 162 (1999) 2946-2955
129. Phillips R., Stubbs V.E.L.S., Henson M.R., Williams T.J., Pease J.E., and Sabroe I. Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter. J Immunol 170 (2003) 6190-6201
130. Alam R., York J., Boyars M., Stafford S., Grant J.A., Lee J., et al. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 153 (1996) 1398-1404
131. Tillie-Leblond I., Hammad H., Desurmont S., Pugin J., Wallaert B., Tonnel A.B., et al. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment. Am J Respir Crit Care Med 162 (2000) 586-592
132. Holgate S.T., Bodey K.S., Janezic A., Frew A.J., Kaplan A.P., and Teran L.M. Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 156 (1997) 1377-1383
133. Kaburagi Y., Shimada Y., Nagaoka T., Hasegawa M., Takehara K., and Sato S. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 293 (2001) 350-355
134. Campbell E.M., Kunkel S.L., Strieter R.M., and Lukacs N.W. Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. J Immunol 161 (1998) 7047-7053
135. Blease K., Mehrad B., Standiford T.J., Lukacs N.W., Kunkel S.L., Chensue S.W., et al. Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease. J Immunol 165 (2000) 1564-1572
136. Nagase H., miyamasu M., Yamaguchi M., Fujisawa T., Ohta K., Yamamoto K., et al. Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation. J Immunol 164 (2000) 5935-5943
137. Martin C., Burdon P.C.E., Bridger G., Gutierrez-Ramos J.-C., Williams T.J., and Rankin S.M. The balance between chemokines acting via CXCR4 and CXCR2 determines the release of neutrophils from the bone marrow and their return following senescence. Immunity 19 (2003) 583-593
138. Iikura M., Miyamasu M., Yamaguchi M., Kawasaki H., Matsushima K., Kitaura M., et al. Chemokine receptors in human basophils: inducible expression of functional CXCR4. J Leukoc Biol 70 (2001) 113-120
139. Fahy O., Porte H., Senechal S., Vorng H., McEuen A.R., Buckley M.G., et al. Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin. Am J Pathol 158 (2001) 1053-1063
140. Kuna P., Alam R., Ruta U., and Gorski P. RANTES induces nasal mucosal inflammation rich in eosinophils, basophils, and lymphocytes in vivo. Am J Respir Crit Care Med 157 (1998) 873-879
141. Conti P., Pang X., Boucher W., Letourneau R., Reale M., Barbacane R.C., et al. Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89 (1997) 4120-4127
142. Jinquan T., Jacobi H.H., Jing C., Reimert C.M., Quan S., Dissing S., et al. Chemokine stromal cell-derived factor 1alpha activates basophils by means of CXCR4. J Allergy Clin Immunol 106 (2000) 313-320
143. Alam R., Forsythe P.A., Stafford S., Lett-Brown M.A., and Grant J.A. Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J Exp Med 176 (1992) 781-786
144. Kuna P., Reddigari S.R., Rucinski D., Oppenheim J.J., and Kaplan A.P. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med 175 (1992) 489-493
145. Dahinden C.A., Geiser T., Brunner T., Von Tscharner V., Caput D., Ferrara P., et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 179 (1994) 751-756
146. Garcia-Zepeda E.A., Combadiere C., Rothenberg M.E., Sarafi M.N., Lavigne F., Hamid Q., et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 157 (1996) 5613-5626
147. Heinemann A., Hartnell A., Stubbs V.E., Murakami K., Soler D., LaRosa G., et al. Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling. J Immunol 165 (2000) 7224-7233
148. Power C.A., Nemeth K., Bacon K., Hoogewerf A.J., Proudfoot A.E.I., and Wells T.N.C. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 270 (1995) 19495-19500
149. Menzies-Gow A., Ying S., Sabroe I., Stubbs V.L., Soler D., Williams T.J., et al. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol 169 (2002) 2712-2718
150. Li H., Sim T.C., Grant J.A., and Alam R. The production of macrophage inflammatory protein-1 alpha by human basophils. J Immunol 157 (1996) 1207-1212
151. Boyce J.A., Mellor E.A., Perkins B., Lim Y.C., and Luscinskas F.W. Human mast cell progenitors use alpha4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions. Blood 99 (2002) 2890-2896
152. Brightling C.E., Ammit A.J., Kaur D., Black J.L., Wardlaw A.J., Hughes J.M., et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 171 (2005) 1103-1108
153. Juremalm M., Hjertson M., Olsson N., Harvima I., Nilsson K., and Nilsson G. The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol 30 (2000) 3614-3622
154. Juremalm M., Olsson N., and Nilsson G. Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem Biophys Res Commun 297 (2002) 480-485
155. Romagnani P., De Paulis A., Beltrame C., Annunziato F., Dente V., Maggi E., et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 155 (1999) 1195-1204
156. Abonia J.P., Austen K.F., Rollins B.J., Joshi S.K., Flavell R.A., Kuziel W.A., et al. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 105 (2005) 4308-4313
157. Toda M., Dawson M., Nakamura T., Munro P.M., Richardson R.M., Bailly M., et al. Impact of Engagement of FcepsilonRI and CC chemokine receptor 1 on mast cell activation and motility. J Biol Chem 279 (2004) 48443-48448
158. Miyazaki D., Nakamura T., Toda M., Cheung-Chau K.W., Richardson R.M., and Ono S.J. Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J Clin Invest 115 (2005) 434-442
159. Nakamura T., Ohbayashi M., Toda M., Hall D.A., Horgan C.M., and Ono S.J. A specific CCR3 chemokine receptor antagonist inhibits both early and late phase allergic inflammation in the conjunctiva. Immunol Res 33 (2005) 213-221
160. Heath H., Qin S., Wu L., LaRosa G., Kassam N., Ponath P.D., et al. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 99 (1997) 178-184
161. Sabroe I., Conroy D.M., Gerard N.P., Li Y., Collins P.D., Post T.W., et al. Cloning and characterisation of the guinea pig eosinophil eotaxin receptor, CCR3: blockade using a monoclonal antibody in vivo. J Immunol 161 (1998) 6139-6147
162. Zhang L., Soares M.P., Guan Y., Matheravidathu S., Wnek R., Johnson K.E., et al. Functional expression and characterization of macaque C-C chemokine receptor 3 (CCR3) and generation of potent antagonistic anti-macaque CCR3 monoclonal antibodies. J Biol Chem 277 (2002) 33799-33810
163. Sabroe I., Peck M.J., Jan Van Keulen B., Jorritsma A., Simmons G., Clapham P.R., et al. A small molecule antagonist of the chemokine receptors CCR1 and CCR3: potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. J Biol Chem 275 (2000) 25985-25992
164. White J.R., Lee J.M., Dede K., Imburgia C.S., Jurewicz A.J., Chan G., et al. Identification of potent, selective non-peptide CCR3 antagonist that inhibits eotaxin-1, eotaxin-2 and MCP-4 induced eosinophil migration. J Biol Chem 275 (2000) 36626-36631
165. Naya A., Kobayashi K., Ishikawa M., Ohwaki K., Saeki T., Noguchi K., et al. Discovery of a novel CCR3 selective antagonist. Bioorg Med Chem Lett 11 (2001) 1219-1223
166. Dhanak D., Christmann L.T., Darcy M.G., Keenan R.M., Knight S.D., Lee J., et al. Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2. Bioorg Med Chem Lett 11 (2001) 1445-1450
167. Varnes J.G., Gardner D.S., Santella III J.B., Duncia J.V., Estrella M., Watson P.S., et al. Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists. Bioorg Med Chem Lett 14 (2004) 1645-1649
168. Wells T.N., Power C.A., Shaw J.P., and Proudfoot A.E. Chemokine blockers-therapeutics in the making?. Trends Pharmacol Sci 27 (2006) 41-47
169. Morokata T., Suzuki K., Masunaga Y., Taguchi K., Morihira K., Sato I., et al. A novel, selective, and orally available antagonist for CC chemokine receptor 3. J Pharmacol Exp Ther 317 (2006) 244-250
170. Suzuki K., Morokata T., Morihira K., Sato I., Takizawa S., Kaneko M., et al. In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031. Biochem Biophys Res Commun 339 (2006) 1217-1223
171. Warrior U., McKeegan E.M., Rottinghaus S.M., Garcia L., Traphagen L., Grayson G., et al. Identification and characterization of novel antagonists of the CCR3 receptor. J Biomol Screen 8 (2003) 324-331
172. GSK Annual Report 2004. Available at: http://www.gsk.com/investors/reps04/20F-2004.pdf. Accessed 2004.
173. Fryer A.D., Stein L.H., Nie Z., Curtis D.E., Evans C.M., Hodgson S.T., et al. Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J Clin Invest 116 (2006) 228-236
174. de Mendonca F.L., da Fonseca P.C., Phillips R.M., Saldanha J.W., Williams T.J., and Pease J.E. Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist. J Biol Chem 280 (2005) 4808-4816
175. Ying S., Robinson D.S., Meng Q., Rottman J., Kennedy R., Ringler D.J., et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 27 (1997) 3507-3516
176. Berkman N., Ohnona S., Chung F.K., and Breuer R. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol 24 (2001) 682-687
177. Zeibecoglou K., Macfarlane A.J., Ying S., Meng Q., Pavord I., Barnes N.C., et al. Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge. Allergy 54 (1999) 730-735
178. Yamada H., Yamaguchi M., Yamamoto K., Nakajima T., Hirai K., Morita Y., et al. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum. Allergy 55 (2000) 392-397
179. Powell N., Humbert M., Durham S.R., Assoufi B., Kay A.B., and Corrigan C.J. Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur Respir J 9 (1996) 2454-2460
180. Berkman N., Krishnan V.L., Gilbey T., Newton R., O'Conner B., Barnes P.J., et al. Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am J Respir Crit Care Med 154 (1997) 1804-1811
181. Rajakulasingam K., Hamid Q., O'Brien F., Shotman E., Jose P.J., Williams T.J., et al. RANTES in human allergen-induced rhinitis: cellular source and relation to tissue eosinophilia. Am J Respir Crit Care Med 155 (1997) 696-703
182. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107 (2001) 535-541
183. Vestergaard C., Bang K., Gesser B., Yoneyama H., Matsushima K., and Larsen C.G. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 115 (2000) 640-646
184. Sauty A., Dziejman M., Taha R.A., Iarossi A.S., Neote K., Garcia-Zepeda E.A., et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 162 (1999) 3549-3558
185. Campbell J.J., Brightling C.E., Symon F.A., Qin S., Murphy K.E., Hodge M., et al. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol 166 (2001) 2842-2848
186. Klunker S., Trautmann A., Akdis M., Verhagen J., Schmid-Grendelmeier P., Blaser K., et al. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J Immunol 171 (2003) 1078-1084